| View |
|
DRP-5769-08
|
Gliclazide
|
Diamopsiv
|
30 mg
|
Modified-Release Tablet
|
Oral Hypoglycemic Agent
|
Bal Pharma Ltd.
|
India
|
Renewal
|
15 May 2024
|
13 June 2029
|
| View |
|
DRP-5769-09
|
Gliclazide
|
Giclaz
|
30 mg
|
Modified-Release Tablet
|
Oral Hypoglycemic Agent
|
Bal Pharma Ltd.
|
India
|
Renewal
|
12 June 2024
|
13 June 2029
|
| View |
|
DRP-12991-02
|
Mupirocin
|
Mupicare
|
20mg/g (2% w/w)
|
Topical Ointment
|
-
|
Opal Laboratories (Pvt.) Limited
|
Pakistan
|
CLIDP Conversion
|
31 May 2023
|
14 November 2027
|
| View |
|
DRP-13817
|
Cefotaxime (as sodium)
|
SITICEF
|
1 g
|
Powder for Injection (I.M./I.V.)
|
Antibacterial (Cephalosporins)
|
Bosch Pharmaceutical (Pvt.) Ltd.
|
Pakistan
|
Renewal
|
18 August 2023
|
15 October 2028
|
| View |
|
DRP-13818
|
Ceftriaxone Sodium
|
SITIAXONE
|
1 g
|
Powder for Injection (I.M./I.V.)
|
Antibacterial (Cephalosporin)
|
Bosch Pharmaceutical (Pvt.) Ltd.
|
Pakistan
|
Renewal
|
18 August 2023
|
02 October 2028
|
| View |
|
DRP-13547
|
Ciprofloxacin (as Lactate)
|
Baxolyn
|
2 mg/mL
|
Solution for Injection (I.V.)
|
-
|
Bosch Pharmaceuticals (Pvt.) Ltd.
|
Pakistan
|
CLIDP Conversion
|
10 March 2023
|
29 September 2026
|
| View |
|
DRP-13567
|
Cefixime (as trihydrate)
|
Fixcef
|
100 mg/5 mL
|
Granules for Suspension
|
-
|
Bosch Pharmaceuticals (Pvt.) Ltd.
|
Pakistan
|
CLIDP Conversion
|
12 March 2023
|
14 August 2026
|
| View |
|
DRP-13575
|
Cefixime (as trihydrate)
|
Fixcef
|
400 mg
|
Capsule
|
-
|
Bosch Pharmaceuticals (Pvt.) Ltd
|
Pakistan
|
CLIDP Conversion
|
14 March 2023
|
18 February 2026
|
| View |
|
DRP-13675
|
Levofloxacin (as hemihydrate)
|
SITI-voux
|
500mg/100mL
|
Solution for IV Infusion
|
Antibacterial (Fluoroquinolone)
|
Bosch Pharmaceuticals (Pvt.) Ltd.
|
Pakistan
|
Renewal
|
25 July 2024
|
29 September 2029
|
| View |
|
DRP-13676
|
Omeprazole (as sodium)
|
SITI-OMEP
|
40 mg
|
Lyophilized Powder for I.V. Infusion
|
Proton Pump Inhibitor
|
Bosch Pharmaceuticals (Pvt.) Ltd.
|
Pakistan
|
Renewal
|
19 May 2024
|
09 July 2029
|
| View |
|
DRP-13689
|
Ceftazidime (as pentahydrate)
|
SITI-ZIDE
|
1 g
|
Powder for Injection (I.V./I.M.)
|
Antibacterial (Cephalosporin)
|
Bosch Pharmaceuticals, Pvt. Ltd
|
Pakistan
|
Renewal
|
16 January 2024
|
05 March 2029
|
| View |
|
DRP-13698
|
Piperacillin (as Sodium) / Tazobactam (as Sodium)
|
Effezolin
|
2.25 gram
|
Powder for Injection (I.V.)
|
Antibacterial (Penicillin)
|
Bosch Pharmaceuticals (Pvt.). Ltd.
|
Pakistan
|
Renewal
|
17 April 2024
|
28 May 2029
|
| View |
|
DRP-13699
|
Piperacillin (as Sodium) / Tazobactam (as Sodium)
|
Effezolin
|
4.5 gram
|
Powder for Injection (I.V.)
|
Antibacterial (Penicillin)
|
Bosch Pharmaceuticals (Pvt.). Ltd.
|
Pakistan
|
Renewal
|
27 May 2024
|
13 July 2029
|
| View |
|
DRP-14279
|
Paracetamol
|
Flugard 500
|
500 mg
|
Tablet
|
-
|
Huazhong Pharmaceutical Co., Ltd.
|
China
|
Initial
|
09 August 2023
|
09 August 2028
|
| View |
|
DR-XY48845
|
Levetiracetam
|
None
|
100 mg/ mL
|
Concentrate for Solution for IV Infusion
|
-
|
Mylan Laboratories Limited (Hosur Sterile Facility)
|
India
|
Initial
|
14 August 2023
|
14 August 2028
|
| View |
|
DRP-14299
|
Hydroxycarbamide
|
Medirea
|
500mg
|
Capsule
|
Other Antineoplastic Agent
|
Laboratorio Eczane Pharma S.A.
|
Argentina
|
Initial
|
14 August 2023
|
14 August 2028
|
| View |
|
DRHR-2276
|
Isopropyl Alcohol
|
None
|
70% (v/v) Topical Solution
|
Topical Solution
|
-
|
Kohl Industries Corporation
|
Philippines
|
Initial
|
16 August 2023
|
16 August 2025
|
| View |
|
DRP-14284
|
Cetirizine Hydrochloride
|
Akrizine
|
10 mg
|
Film-Coated Tablet
|
-
|
AKRITI PHARMACEUTICALS PVT. LTD.
|
India
|
Initial [OTC]
|
10 August 2023
|
10 August 2028
|
| View |
|
DRP-14283
|
Ascorbic Acid
|
Yorabic-C
|
500 mg
|
Chewable Tablet
|
-
|
MEDISKY PHARMACEUTICALS
|
India
|
Initial [OTC]
|
10 August 2023
|
10 August 2028
|
| View |
|
DRP-14285
|
Bisacodyl
|
Laxavis
|
5 mg
|
Enteric-Coated Tablet
|
-
|
Acme Life Tech LLP
|
India
|
Initial [OTC]
|
10 August 2023
|
10 August 2028
|